These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25495664)

  • 1. Is pathology necessary to predict mortality among men with prostate-cancer?
    Margel D; Urbach DR; Lipscombe LL; Bell CM; Kulkarni G; Baniel J; Fleshner N; Austin PC
    BMC Med Inform Decis Mak; 2014 Dec; 14():114. PubMed ID: 25495664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
    Margel D; Urbach DR; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
    J Clin Oncol; 2013 Sep; 31(25):3069-75. PubMed ID: 23918942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of colorectal cancer after the diagnosis of prostate cancer: A population-based study.
    Desautels D; Czaykowski P; Nugent Z; Demers AA; Mahmud SM; Singh H
    Cancer; 2016 Apr; 122(8):1254-60. PubMed ID: 26919270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weighted versus unweighted Charlson score to predict long-term other-cause mortality in men with early-stage prostate cancer.
    Daskivich TJ; Kwan L; Dash A; Greenfield S; Litwin MS
    Eur Urol; 2014 Dec; 66(6):1002-9. PubMed ID: 24924554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular comorbidity and mortality in men with prostate cancer treated with brachytherapy-based radiation with or without hormonal therapy.
    Nanda A; Chen MH; Moran BJ; Braccioforte MH; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e209-15. PubMed ID: 23332383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer.
    Berglund A; Garmo H; Robinson D; Tishelman C; Holmberg L; Bratt O; Adolfsson J; Stattin P; Lambe M
    Eur J Cancer; 2012 Jan; 48(1):75-84. PubMed ID: 21852113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer mortality in the Finnish randomized screening trial.
    Kilpeläinen TP; Tammela TL; Malila N; Hakama M; Santti H; Määttänen L; Stenman UH; Kujala P; Auvinen A
    J Natl Cancer Inst; 2013 May; 105(10):719-25. PubMed ID: 23479454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the Johns Hopkins' Aggregated Diagnosis Groups (ADGs) to predict 1-year mortality in population-based cohorts of patients with diabetes in Ontario, Canada.
    Austin PC; Shah BR; Newman A; Anderson GM
    Diabet Med; 2012 Sep; 29(9):1134-41. PubMed ID: 22212006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
    Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
    Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Mortality Prediction in Dialysis Patients Using Specific Clinical and Laboratory Data.
    Hemke AC; Heemskerk MB; van Diepen M; Dekker FW; Hoitsma AJ
    Am J Nephrol; 2015; 42(2):158-67. PubMed ID: 26406283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
    Shen W; Sakamoto N; Yang L
    Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved prediction of long-term, other cause mortality in men with prostate cancer.
    Daskivich TJ; Chamie K; Kwan L; Labo J; Dash A; Greenfield S; Litwin MS
    J Urol; 2011 Nov; 186(5):1868-73. PubMed ID: 21944092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
    Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
    Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction.
    Nanda A; Chen MH; Braccioforte MH; Moran BJ; D'Amico AV
    JAMA; 2009 Aug; 302(8):866-73. PubMed ID: 19706860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer.
    Tendulkar RD; Hunter GK; Reddy CA; Stephans KL; Ciezki JP; Abdel-Wahab M; Stephenson AJ; Klein EA; Mahadevan A; Kupelian PA
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):94-9. PubMed ID: 23920389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a comorbidity scoring system for patients with cirrhosis.
    Jepsen P; Vilstrup H; Lash TL
    Gastroenterology; 2014 Jan; 146(1):147-56; quiz e15-6. PubMed ID: 24055278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
    Walz J; Chun FK; Klein EA; Reuther A; Saad F; Graefen M; Huland H; Karakiewicz PI
    J Urol; 2009 Feb; 181(2):601-7; discussion 607-8. PubMed ID: 19084864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL.
    Ang M; Rajcic B; Foreman D; Moretti K; O'Callaghan ME
    BJU Int; 2016 Apr; 117 Suppl 4():68-75. PubMed ID: 26890320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing age within established Gleason score categories and the risk of prostate cancer-specific mortality (PCSM).
    Russo AL; Chen MH; Aizer AA; Hattangadi JA; D'Amico AV
    BJU Int; 2012 Oct; 110(7):973-9. PubMed ID: 22954029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of obesity on overall and cancer specific survival in men with prostate cancer.
    Davies BJ; Smaldone MC; Sadetsky N; Dall'era M; Carroll PR
    J Urol; 2009 Jul; 182(1):112-7; discussion 117. PubMed ID: 19447437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.